drugset / Trial / NCT04151407
The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)
Non-randomizedSequentialOpen-labelTreatment
Summary
Observe the safety and tolerability of the single and multiple doses of 601 in DME patients; study the pharmacokinetic characteristics of single and multiple doses of 601, Observe the Preliminary efficacy of 601 multiple injections with different doses in the treatment of patients with DME.
Timeline
- Start
- 2019-03-08
- Primary completion
- 2020-12
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Drug 601 | Monoclonal antibody | 0.375 mg | Other |
| Subject | Drug 601 | Monoclonal antibody | 0.75 mg | Other |
| Subject | Drug 601 | Monoclonal antibody | 1.25 mg | Other |
| Subject | Drug 601 | Monoclonal antibody | 2.5 mg | Other |
| Subject | Drug 601 | Monoclonal antibody | 3.75 mg | Other |